Colonoscopy Devices Market Analysis & Forecast: 2025-2032

Colonoscopy Devices Market Analysis & Forecast - 2025 to 2032

Colonoscopy devices market is estimated to be valued at USD 2,766.8 Mn in 2025 and is expected to reach USD 3,945.4 Mn in 2032, exhibiting a compound annual growth rate (CAGR) of 5.2% from 2025 to 2032.

Key Takeaways

• By Component, the Colonoscope segment is projected to dominate the global colonoscopy devices market with a 38.8% share in 2025. This dominance stems from the essential role colonoscopes play in diagnostic and therapeutic procedures for colorectal diseases, particularly colorectal cancer screening.
• By Region, North America is expected to lead the global colonoscopy devices market in 2025, accounting for a substantial 38.8% share. The region’s dominance is supported by a well-established healthcare infrastructure, high prevalence of colorectal cancer, and favourable reimbursement policies for colorectal screening procedures.

Market Overview

The global colonoscopy devices market is witnessing steady growth, driven by the rising incidence of colorectal cancer, increasing awareness about early diagnosis, and the growing adoption of minimally invasive procedures. Colonoscopes remain the leading component due to their critical role in screening and diagnosis. North America dominates the global landscape, supported by robust healthcare infrastructure and favourable screening guidelines.

Current Events and Its Impact on the Colonoscopy Devices Market

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

Impact of AI (Artificial Intelligence) on the Global Colonoscopy Devices Market

The colonoscopy devices market is experiencing a revolutionary transformation through artificial intelligence integration, fundamentally changing how colorectal cancer screening and diagnosis are performed. AI technology is enhancing detection accuracy, reducing procedure times, and improving patient outcomes across the healthcare spectrum.

For instance, Medtronic served as the exclusive global distributor of Cosmo Pharmaceutical’s GI Genius module, which had been granted De Novo clearance and was compatible with colonoscope video for the identification of precancerous polyps and lesions. In addition to the United States, the AI-assisted system was available in Europe and select markets across Asia, Australia, and the Middle East.

Colonoscopy Devices Market Trends

• Rise in focus on disease diagnosis is a recent trend

Several hospitals across the globe have started using advanced technologies, such as AI and 5G, with colonoscopy to drastically improve the quality of diagnosis of various cancers. For example, in December 2022, Apollo Hospitals and Bharti Airtel carried out India’s first ever AI-guided and 5G-driven colonoscopy trials. The trials were conducted in collaboration with tech firms, such as Avesha, HealthNet Global, and Amazon Web Services to improve the speed and accuracy in the detection of colon cancer. This trend is expected to continue over the forecast period.

• Introduction of novel drugs is another trend

With the growing number of colonoscopy procedures, the demand for colonoscopy devices is also increasing rapidly. As a result, players in the market are focusing on developing/launching novel devices in the market.

Segmental Insights

To learn more about this report, Download Free Sample

Global Colonoscopy Devices Market Insights, By Component

The colonoscope segment is projected to dominate the global colonoscopy devices market with a 38.8% share in 2025. This dominance stems from the critical role colonoscopes play in both diagnostic and therapeutic procedures for colorectal conditions, particularly in colorectal cancer screening programs.

Technological advancements such as high-definition and narrow-band imaging, along with AI-assisted detection modules are significantly enhancing lesion identification and procedural accuracy. The rising demand for infection control is also fuelling the shift toward single-use and robotic-assisted colonoscopes, offering benefits like reduced cross-contamination and operational efficiency.

Although accessories and visualization systems remain important, the colonoscope continues to serve as the cornerstone of endoscopic practice, ensuring its sustained leadership in both hospitals and ambulatory surgical centres.

 Regional Insights

To learn more about this report, Download Free Sample

North America Colonoscopy Devices Market Trends and Analysis

North America is expected to lead the global colonoscopy devices market in 2025, accounting for a substantial 38.80% share. This dominance is supported by a well-established healthcare infrastructure, widespread awareness about colorectal health, and a high prevalence of colorectal cancer, particularly in the United States.

Strong government initiatives aimed at promoting early cancer detection such as regular screening programs and coverage under Medicare and private insurers significantly contribute to market expansion. The U.S. benefits from a robust network of endoscopy centres, advanced technology adoption, and skilled gastroenterologists.

Additionally, the region's aging population and growing emphasis on preventive care continue to drive demand for colonoscopy procedures. While Europe and Asia Pacific are witnessing increased adoption and procedural volumes, North America remains the epicentre for innovation, reimbursement support, and procedure frequency in the colonoscopy devices market.

Colonoscopy Devices Market Dominating Countries

United States and Canada

The United States dominates the global colonoscopy devices market due to its high incidence of colorectal cancer, established healthcare infrastructure, and widespread adoption of advanced medical technologies. Federal initiatives like Medicare coverage for screening and awareness campaigns under the CDC’s Colorectal Cancer Control Program (CRCCP) have driven early diagnosis and regular colonoscopy procedures. The U.S. also leads in AI-assisted endoscopy innovations and hosts a robust network of ambulatory surgical centres and hospitals with advanced endoscopic suites.

Canada complements regional growth with increasing investments in colorectal cancer prevention and screening programs such as the ColonCancerCheck initiative. Public healthcare support, aging demographics, and growing use of high-definition and minimally invasive colonoscopy devices are driving market expansion. With both nations focused on improving healthcare accessibility and early detection, North America remains a powerhouse in the global colonoscopy devices landscape.

Market Report Scope

Analyst Viewpoint – Colonoscopy Devices Market

• The global colonoscopy devices market, driven by the increasing global burden of colorectal cancer and the growing emphasis on preventive healthcare. Analysts highlight that rising awareness, favourable reimbursement policies, and government-led screening initiatives are significantly boosting procedure volumes, particularly in developed markets like the U.S., Germany, and Japan. The adoption of colonoscopy as the gold standard for colorectal screening ensures steady demand for advanced devices.
• Experts emphasize the growing integration of artificial intelligence (AI) and high-definition imaging technologies into colonoscopy systems. AI-enabled devices, such as the GI Genius module by Medtronic, are expected to improve adenoma detection rates (ADR), reduce physician fatigue, and improve patient outcomes. Analysts view these advancements as key differentiators in an otherwise mature market.
• Regionally, North America remains the leading market, supported by robust healthcare infrastructure and procedural reimbursements. However, Asia Pacific is expected to witness the fastest growth, driven by urbanization, rising disposable income, and government investments in public health screening.
• Looking ahead, analysts believe the market will be shaped by innovation, with trends such as single-use colonoscopes, robotics-assisted procedures, and AI-assisted diagnostics playing a central role. Market players are expected to focus on affordability, infection control, and expanding procedural access in emerging economies to capture long-term growth opportunities.

Colonoscopy Devices Market: Key Development

• In May 2025, Olympus received FDA 510(k) clearance for its new CF‑EZ1500DL/I colonoscope, featuring Extended Depth of Field (EDOF) imaging and compatibility with AI-enhanced EVIS X1 systems. EDOF technology delivers consistently sharp images across the colon wall, improving polyp detection and reducing procedural time boosting clinician confidence and enabling faster adoption of advanced imaging scopes.
• In October 2024, the next-generation Cologuard Plus stool DNA test earned FDA approval, enhancing accuracy in colorectal cancer screening. While offering a less invasive alternative, its high diagnostic performance may further increase colonoscopy referrals, supporting device usage and procedural volume growth.
• In June 2023, Virtua began using artificial intelligence (A.I.) to help doctors detect the presence of possible precancerous lesions during colonoscopies.

Market Segmentation

• Global Colonoscopy Devices Market, By Component
• Colonoscope
• Visualization Systems
• Others
• Global Colonoscopy Devices Market, By End User
• Hospitals and Ambulatory Surgery Centers
• Diagnostic Centers
• Clinics
• Global Colonoscopy Devices Market, By Geography
• North America
• U.S.
• Canada
• Latin America
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• Europe
• Germany
• U.K.
• Spain
• France
• Italy
• Russia
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• GCC Countries
• Israel
• Rest of Middle East
• Africa
• South Africa
• North Africa
• Central Africa
• Key Players Insights
• Karl Storz SE & Co. KG
• Olympus Corporation
• Endo Med Systems GmbH
• HOYA Corporation
• Getinge AB
• Avantis Medical Systems
• Boston Scientific Corporation
• FUJIFILM Holdings Corporation

Sources

The Stakeholders Consulted

• Gastroenterologists and colorectal surgeons
• Endoscopy equipment manufacturers and suppliers
• Hospital procurement managers and surgical centre administrators
• Biomedical engineers and equipment maintenance specialists
• Regulatory and compliance officers in healthcare institutions
• Research institutions focused on gastrointestinal diagnostics
• Health insurance experts and reimbursement policy analysts
• Medical device distributors and channel partners
• Public and private healthcare infrastructure developers

Databases Opened

• U.S. Food and Drug Administration (FDA)
• Centers for Medicare & Medicaid Services (CMS)
• World Health Organization (WHO)
• National Institutes of Health (NIH)
• Global Health Observatory (GHO)

Magazines & Trade Publications

• MedTech Insight
• Medical Design & Outsourcing
• HealthCare Business News
• DeviceTalks
• Diagnostic and Interventional Endoscopy Journal

Scientific and Industry Journals

• Gastrointestinal Endoscopy (GIE) Journal
• Digestive Diseases and Sciences
• Journal of Medical Devices
• Endoscopy International Open
• Journal of Clinical Gastroenterology

Newspapers & Media Outlets

• The Wall Street Journal – Health & Technology
• Bloomberg – Medical Devices and Healthcare Markets
• Reuters Health – Diagnostics and Therapeutic Devices
• The Economic Times – MedTech and Hospital Equipment News
• Business Standard – Indian Healthcare Industry Reports

Associations and Regulatory Bodies

• U.S. Food and Drug Administration (FDA)
• American Society for Gastrointestinal Endoscopy (ASGE)
• European Society of Gastrointestinal Endoscopy (ESGE)
• World Endoscopy Organization (WEO)
• Central Drugs Standard Control Organization (CDSCO), India

Public Domain Sources

• U.S. Centers for Disease Control and Prevention (CDC) – Colorectal Cancer Data
• European Commission – Medical Device Regulations and CE Marking Updates
• World Bank – Healthcare Infrastructure Investments
• OECD Health Statistics – Medical Technology Use Trends

Proprietary Research Elements

• CMI Data Analytics Tool
• Proprietary CMI Repository of Market Data (covering past 8 years)
• CMI Expert Interviews and Transcripts (focused on endoscopy systems, GI diagnostics, and hospital procurement trends)